BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12559508)

  • 1. Remyelination in multiple sclerosis.
    Brück W; Kuhlmann T; Stadelmann C
    J Neurol Sci; 2003 Feb; 206(2):181-5. PubMed ID: 12559508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remyelination in multiple sclerosis.
    Lassmann H; Brück W; Lucchinetti C; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin of remyelinating cells in the central nervous system.
    Blakemore WF; Keirstead HS
    J Neuroimmunol; 1999 Jul; 98(1):69-76. PubMed ID: 10426364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex.
    Mezydlo A; Treiber N; Ullrich Gavilanes EM; Eichenseer K; Ancău M; Wens A; Ares Carral C; Schifferer M; Snaidero N; Misgeld T; Kerschensteiner M
    Neuron; 2023 Jun; 111(11):1748-1759.e8. PubMed ID: 37071991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving concepts and issues in remyelination.
    Ludwin SK
    Dev Neurosci; 1989; 11(2):140-8. PubMed ID: 2663422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of oligodendroglia pathology in multiple sclerosis.
    Ozawa K; Suchanek G; Breitschopf H; Brück W; Budka H; Jellinger K; Lassmann H
    Brain; 1994 Dec; 117 ( Pt 6)():1311-22. PubMed ID: 7820568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
    Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
    Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
    Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
    [No Abstract]   [Full Text] [Related]  

  • 15. Remyelination in multiple sclerosis.
    Chari DM
    Int Rev Neurobiol; 2007; 79():589-620. PubMed ID: 17531860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelinating strategies for the treatment of multiple sclerosis.
    Stangel M; Hartung HP
    Prog Neurobiol; 2002 Dec; 68(5):361-76. PubMed ID: 12531235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?
    Franklin RJ; Blakemore WF
    Mult Scler; 1997 Apr; 3(2):84-7. PubMed ID: 9291159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin repair strategies: a cellular view.
    Gallo V; Armstrong RC
    Curr Opin Neurol; 2008 Jun; 21(3):278-83. PubMed ID: 18451710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.